SMITHKLINE BEECHAM RELAFEN DIRECT-TO-CONSUMER ADS BREAKING IN MID-MARCH
Executive Summary
SMITHKLINE BEECHAM RELAFEN DIRECT-TO-CONSUMER ADS BREAKING IN MID-MARCH issues of Reader's Digest, American Health, Time and U.S. News and World Report, SmithKline Beecham announced Feb. 23. The print ads will refer readers to a toll-free number (800-734- 1543) to call for an information booklet about the nonsteroidal anti-inflammatory drug Relafen (nabumetone). The ads were designed by Ogilvy & Mather.